1. |
Key G, Becher MHG, Duchrow M, et al. New Ki67 equivalent murine monoclonal antibodies (MiB1) prepared against recombinant parts of the Ki67 antigen 〔J〕. Anal Cell Pathol, 1992; 4(2)∶181.
|
2. |
Moul JW, Bettencourt MC, Sesterhern IA, et al. Protein expression of p53, bcl2 and Ki67 (MiB1) as prognostic biomarkers in patients with surgically treated, clinically localized prostate cancer 〔J〕. Surgery, 1996; 120(2)∶159.
|
3. |
Lam KY, Law SY, So MK, et al. Prognostic implication of proliferative markers MiB1 and PC10 in esophageal squamous cell carcinoma 〔J〕. Cancer, 1996; 77(1)∶7.
|
4. |
Japanese research society for gastric cancer. The general rules for the gastric study 〔C〕. 12th endition. Tokyo. Kanehara & CO, LTD.1993∶1-53.
|
5. |
Muller W, Schneiders A, Meier S, et al. Immunohistochemical study on the prognosis value of MiB 1 in gastric carcinoma 〔J〕. Br J Cancer, 1996; 74(5)∶759.
|
6. |
Frank RE, Saclarides TJ, Leurgans S, et al. Tumor angiogenesis as a predicator of recurrence and survival in patients with nodenegative colon cancer 〔J〕. Anal Surg, 1995; 222(6)∶695.
|
7. |
Kimura H, Yonemura Y, Epstein AL. Flowcytometric quantitation of the proliferation associated nuclear antigen p105 and DNA content in advanced gastric cancer 〔J〕. Cancer, 1991; 68(12)∶2175.
|
8. |
Saitoh K, Chiba T, Nakamura K. Cell proliferation kinetics of human gastric carcinoma:an immunohistochemical study with a monoclonal antibody against DNA polymeraseα 〔J〕. Euro J Cancer, 1992; 28(10)∶1642.
|
9. |
車向明,帆北修一,愛甲孝.70歲以上老年人早期胃癌的臨床病理特點 〔J〕.中國普通外科雜志,1997; 6(3)∶129.
|
10. |
車向明,帆北修一,愛甲孝.早期胃癌的臨床病理特點 〔J〕.西安醫科大學學報,1997; 8(2)∶15.
|
11. |
Kidama Y, Inoduchi K, Spejima K, et al. Growth patterns and prognosis in early gastric carcinoma superficially spreading and penetrating growth types 〔J〕. Cancer , 1983; 52(2)∶320.
|